Cardiff Oncology Inc (NAS:CRDF) Stock News, Headlines & Updates
Cardiff Oncology Inc Stock News from GuruFocus
- 1
Jul 08, 2025
Cardiff Oncology (CRDF) Receives New Coverage with "Buy" Rating | CRDF Stock News
GuruFocus News • 2:30pm
Jun 24, 2025
Jefferies Initiates Coverage on Cardiff Oncology (CRDF) with Hold Rating | CRDF Stock News
GuruFocus News • 8:00am
Cardiff Oncology (CRDF) Begins Coverage With Hold Rating from Jefferies | CRDF Stock News
GuruFocus News • 4:45am
Jun 18, 2025
Cardiff Oncology (CRDF) Stock Reacts to Delayed Clinical Data Update | CRDF Stock News
GuruFocus News • 8:45am
CRDF Set to Release Key Clinical Data Amid Leadership Changes | CRDF Stock News
GuruFocus News • 8:45am
Jun 17, 2025
Cardiff Oncology (CRDF) Shares Drop 11% After Leadership Change
GuruFocus News • 4:55pm
Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC
Marketwired • 4:00pm
Cardiff Oncology (CRDF) Welcomes New Chief Medical Officer | CRDF Stock News
GuruFocus News • 3:30pm
Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC | CRDF Stock News
GuruFocus News • 3:17pm
Jun 02, 2025
Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025
Marketwired • 4:00pm
Cardiff Oncology (CRDF) Reports Promising Phase 1b Trial Results for Breast Cancer Treatment | CRDF Stock News
GuruFocus News • 3:30pm
Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025 | CRDF Stoc
GuruFocus News • 3:17pm
May 30, 2025
Cardiff Oncology (CRDF) Emerges as a Prime M&A Target
GuruFocus News • 2:55pm
May 09, 2025
Cardiff Oncology (CRDF) Gains Analyst Confidence with Price Target Increase | CRDF Stock News
GuruFocus News • 8:30am
Cardiff Oncology (CRDF) Price Target Increased by Analyst | CRDF Stock News
GuruFocus News • 5:50am
May 08, 2025
Cardiff Oncology (CRDF) Reports Strong Q1 Revenue and Advances Cancer Therapy | CRDF Stock News
GuruFocus News • 4:25pm
Cardiff Oncology Reports First Quarter 2025 Results and Provides Business Update
Marketwired • 4:00pm
Cardiff Oncology Q1 2025 Earnings: EPS Misses at -$0.20, Revenue Slightly Beats at $0.11 Million
GuruFocus News • 3:51pm
Apr 23, 2025
Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
Marketwired • 4:00pm
Cardiff Oncology (CRDF) Secures New U.S. Patent for Cancer Treatment Method | CRDF Stock News
GuruFocus News • 3:31pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news